PortalPublikationenHLA and bone marrow transplantation.

HLA and bone marrow transplantation.

Standard

HLA and bone marrow transplantation. / Eiermann, Thomas.

in: ARCH IMMUNOL THER EX, Jahrgang 43, Nr. 2, 2, 1995, S. 83-87.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Eiermann, T 1995, 'HLA and bone marrow transplantation.', ARCH IMMUNOL THER EX, Jg. 43, Nr. 2, 2, S. 83-87. <http://www.ncbi.nlm.nih.gov/pubmed/8744720?dopt=Citation>

APA

Eiermann, T. (1995). HLA and bone marrow transplantation. ARCH IMMUNOL THER EX, 43(2), 83-87. [2]. http://www.ncbi.nlm.nih.gov/pubmed/8744720?dopt=Citation

Vancouver

Eiermann T. HLA and bone marrow transplantation. ARCH IMMUNOL THER EX. 1995;43(2):83-87. 2.

Bibtex

@article{fd7fd4fa1de6473987671afba2e0b19e,
title = "HLA and bone marrow transplantation.",
abstract = "Bone marrow transplantation between HLA-identical siblings is an established therapeutic strategy in leukemia and a variety of lympho-hematopoietic disorders. In recent years unrelated donors were increasingly used for patients lacking a family donor. Here we report on current progress in HLA class II typing by molecular methods which have influenced donor search and improved matching.",
author = "Thomas Eiermann",
year = "1995",
language = "Deutsch",
volume = "43",
pages = "83--87",
journal = "ARCH IMMUNOL THER EX",
issn = "0004-069X",
publisher = "Birkhauser Verlag Basel",
number = "2",

}

RIS

TY - JOUR

T1 - HLA and bone marrow transplantation.

AU - Eiermann, Thomas

PY - 1995

Y1 - 1995

N2 - Bone marrow transplantation between HLA-identical siblings is an established therapeutic strategy in leukemia and a variety of lympho-hematopoietic disorders. In recent years unrelated donors were increasingly used for patients lacking a family donor. Here we report on current progress in HLA class II typing by molecular methods which have influenced donor search and improved matching.

AB - Bone marrow transplantation between HLA-identical siblings is an established therapeutic strategy in leukemia and a variety of lympho-hematopoietic disorders. In recent years unrelated donors were increasingly used for patients lacking a family donor. Here we report on current progress in HLA class II typing by molecular methods which have influenced donor search and improved matching.

M3 - SCORING: Zeitschriftenaufsatz

VL - 43

SP - 83

EP - 87

JO - ARCH IMMUNOL THER EX

JF - ARCH IMMUNOL THER EX

SN - 0004-069X

IS - 2

M1 - 2

ER -